CN1159037C - Medicine for treating apoplexy - Google Patents

Medicine for treating apoplexy Download PDF

Info

Publication number
CN1159037C
CN1159037C CNB011077506A CN01107750A CN1159037C CN 1159037 C CN1159037 C CN 1159037C CN B011077506 A CNB011077506 A CN B011077506A CN 01107750 A CN01107750 A CN 01107750A CN 1159037 C CN1159037 C CN 1159037C
Authority
CN
China
Prior art keywords
radix
rhizoma
root
herba
fructus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB011077506A
Other languages
Chinese (zh)
Other versions
CN1365819A (en
Inventor
君 李
李君�
伊梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB011077506A priority Critical patent/CN1159037C/en
Publication of CN1365819A publication Critical patent/CN1365819A/en
Application granted granted Critical
Publication of CN1159037C publication Critical patent/CN1159037C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

The present invention discloses a traditional Chinese medicine formula for treating apoplexy, which is prepared from Chinese angelica root, Chuanxiong rhizome, white peony root, prepared rehmannia root, rehmannia root, ginseng, tangerine peel, white tuckahoe, bitter orange, platycodon root, best-quality cinnamon, scorpion, ledebouriella root, batryticated silkworms, pubescent angelica root, ligusticum, mint leaves, bupleurum root, soft plaster stone, wolfberry bark, coptis root, common fennel fruit, dodder, gecko, Chinese ephedra, Gynostemma pentaphyllum, ginkgo leaves, lindera root, notoginseng, white atractylodes rhizome, red sage root, pinellia tuber, aucklandia root, gastrodia tuber, notopterygium root, asarum herb, anemarrhena rhizome, scutellaria root, chastetree fruit, eucommia bark, licorice root, setose thistle and chrysanthemum according to the theory of determining treatment based on differentiation of symptoms in Chinese medicine and signs and the formula principle of traditional Chinese medicines. The present invention has a good function of relieving symptoms, such as hemiplegia, etc. caused by apoplexy.

Description

A kind of medicine for the treatment of apoplexy
The present invention relates to medicine, specifically, is a kind of Chinese prescription for the treatment of apoplexy.
Apoplexy is motherland's medical conditions noun, and pathologic basis such as cerebral hemorrhage, cerebral infarction are often arranged, and often shows as hemiplegia, aphasia even stupor etc., is common cerebrovascular, have recover slow, the course of disease is long, characteristics such as mortality rate height.The treatment means of doctor trained in Western medicine adopts medicament for expanding vascellum more at present, but because there are above characteristics in disease itself, adhere to that for a long time medication usually brings very big mental burden to the patient, and the untoward reaction of Western medicine is often more obvious; Physical therapy and acupuncture then are difficult to obtain sure curative effect.
Purpose of the present invention aims to provide a kind of Chinese prescription that can play fine treatment or relief of symptoms effect to apoplexy.
Solution of the present invention is according to understanding and the determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs principle of the traditional Chinese medical science to apoplexy, processes according to traditional Chinese medical science prescription and preparation principle.
Chinese herbal medicine of the present invention is formed (consumption is a weight portion, and the back is together) by following component:
Radix Angelicae Sinensis (wine is washed): 30~90, Rhizoma Chuanxiong: 40~80, the Radix Paeoniae Alba (wine stir-fry): 30~80, Radix Rehmanniae Preparata: 20~40, the Radix Rehmanniae: 20~40, Radix Ginseng 30~90, Pericarpium Citri Reticulatae: 10~30, Poria: 30~100, Fructus Aurantii: 30~70, Radix Platycodonis (fry and do): 30~90, Cortex Cinnamomi: 20~50, Scorpio (detoxification): 10~30, Radix Saposhnikoviae: 30~90, Bombyx Batryticatus: 20~40, Radix Angelicae Pubescentis: 20~40, Rhizoma Ligustici: 15~40, mentha leave: 30~100, Radix Bupleuri: 30~90, Gypsum Fibrosum: 30~70, Cortex Lycii: 10~30, Rhizoma Coptidis: 30~100, Fructus Foeniculi: 30~100, Semen Cuscutae: 10~30, Gecko (shortcake is processed): 30~70, Herba Ephedrae: 30~100, strand Herba Chlorophyti: 30~90, Folium Ginkgo: 30~100, the Radix Linderae: 5~20, Radix Notoginseng: 5~20, the Rhizoma Atractylodis Macrocephalae: 10~30, Radix Salviae Miltiorrhizae: 5~30, the Rhizoma Pinelliae: 30~100, the Radix Aucklandiae: 30~100, Rhizoma Gastrodiae: 30~80, Rhizoma Et Radix Notopterygii: 30~80, Herba Asari: 5~20, the Rhizoma Anemarrhenae 30~70, Radix Scutellariae: 10~40, graceful Fructus Vitics Simplicifoliae: 10~40, the Cortex Eucommiae (wine stir-fry): 30~70, Radix Glycyrrhizae: 30~90, Radix Cirsii Japonici: 30~100, Flos Chrysanthemi: 10~50.
Optimum ratio of the present invention is:
Radix Angelicae Sinensis (wine is washed): 40~70, Rhizoma Chuanxiong: 45~60, the Radix Paeoniae Alba (wine stir-fry): 40~60, Radix Rehmanniae Preparata: 25~35, the Radix Rehmanniae: 25~35, Radix Ginseng 40~70, Pericarpium Citri Reticulatae: 10~20, Poria: 40~70, Fructus Aurantii: 40~60, Radix Platycodonis (fry and do): 40~70, Cortex Cinnamomi: 25~40, Scorpio (detoxification): 10~20, Radix Saposhnikoviae: 40~70, Bombyx Batryticatus: 25~35, Radix Angelicae Pubescentis: 25~35, Rhizoma Ligustici: 15~30, mentha leave: 40~80, Radix Bupleuri: 40~70, Gypsum Fibrosum: 40~60, Cortex Lycii: 15~25, Rhizoma Coptidis: 40~70, Fructus Foeniculi: 40~70, Semen Cuscutae: 15~25, Gecko (shortcake is processed): 40~60, Herba Ephedrae: 40~70, strand Herba Chlorophyti: 40~70, Folium Ginkgo: 40~80, the Radix Linderae: 10~15, Radix Notoginseng: 10~15, the Rhizoma Atractylodis Macrocephalae: 10~20, Radix Salviae Miltiorrhizae: 10~20, the Rhizoma Pinelliae: 40~70, the Radix Aucklandiae: 40~80, Rhizoma Gastrodiae: 40~60, Rhizoma Et Radix Notopterygii: 40~60, Herba Asari: 10~15, the Rhizoma Anemarrhenae 40~60, Radix Scutellariae: 15~30, graceful Fructus Vitics Simplicifoliae: 10~20, the Cortex Eucommiae (wine stir-fry): 40~60, Radix Glycyrrhizae: 40~70, Radix Cirsii Japonici: 40~80, Flos Chrysanthemi: 15~30.
Optimal proportion of the present invention is:
Radix Angelicae Sinensis (wine is washed): 50, Rhizoma Chuanxiong: 50, the Radix Paeoniae Alba (wine stir-fry): 50, Radix Rehmanniae Preparata: 30, the Radix Rehmanniae: 30, Radix Ginseng 50, Pericarpium Citri Reticulatae: 15, Poria: 50, Fructus Aurantii: 50, Radix Platycodonis (fry and do): 50, Cortex Cinnamomi: 30, Scorpio (detoxification): 15, Radix Saposhnikoviae: 50, Bombyx Batryticatus: 30, Radix Angelicae Pubescentis: 30, Rhizoma Ligustici: 20, mentha leave: 50, Radix Bupleuri: 50, Gypsum Fibrosum: 50, Cortex Lycii: 20, Rhizoma Coptidis: 50, Fructus Foeniculi: 50, Semen Cuscutae: 20, Gecko (shortcake is processed): 50, Herba Ephedrae: 50, the strand Herba Chlorophyti: 50, Folium Ginkgo: 50, the Radix Linderae: 10, Radix Notoginseng: 10, the Rhizoma Atractylodis Macrocephalae: 15, Radix Salviae Miltiorrhizae: 10, the Rhizoma Pinelliae: 50, the Radix Aucklandiae: 60, Rhizoma Gastrodiae: 50, Rhizoma Et Radix Notopterygii: 50, Herba Asari: 10, the Rhizoma Anemarrhenae 50, Radix Scutellariae: 20, graceful Fructus Vitics Simplicifoliae: 15, the Cortex Eucommiae (wine stir-fry): 50, Radix Glycyrrhizae: 50, Radix Cirsii Japonici: 50, Flos Chrysanthemi: 20.
With above medicine is fine powder (refining ball or encapsulated) altogether, and every day three times, each 6~9 grams are oral.
Each component compatibility among the present invention uses can play dredging the meridian, YIN and YANG balance regulating, curing the disease consolidates, reaches the effect of inner disease outer treat, thereby in symptoms such as wind-induced hemiplegia, aphasia treatment or mitigation are preferably arranged, and the present invention does not have obvious toxic-side effects, and the patient comparatively is easy to accept.
Most preferred embodiment of the present invention is as follows:
Radix Angelicae Sinensis (wine is washed): 50, Rhizoma Chuanxiong: 50, the Radix Paeoniae Alba (wine stir-fry): 50, Radix Rehmanniae Preparata: 30, the Radix Rehmanniae: 30, Radix Ginseng 50, Pericarpium Citri Reticulatae: 15, Poria: 50, Fructus Aurantii: 50, Radix Platycodonis (fry and do): 50, Cortex Cinnamomi: 30, Scorpio (detoxification): 15, Radix Saposhnikoviae: 50, Bombyx Batryticatus: 30, Radix Angelicae Pubescentis: 30, Rhizoma Ligustici: 20, mentha leave: 50, Radix Bupleuri: 50, Gypsum Fibrosum: 50, Cortex Lycii: 20, Rhizoma Coptidis: 50, Fructus Foeniculi: 50, Semen Cuscutae: 20, Gecko (shortcake is processed): 50, Herba Ephedrae: 50, the strand Herba Chlorophyti: 50, Folium Ginkgo: 50, the Radix Linderae: 10, Radix Notoginseng: 10, the Rhizoma Atractylodis Macrocephalae: 15, Radix Salviae Miltiorrhizae: 10, the Rhizoma Pinelliae: 50, the Radix Aucklandiae: 60, Rhizoma Gastrodiae: 50, Rhizoma Et Radix Notopterygii: 50, Herba Asari: 10, the Rhizoma Anemarrhenae 50, Radix Scutellariae: 20, graceful Fructus Vitics Simplicifoliae: 15, the Cortex Eucommiae (wine stir-fry): 50, Radix Glycyrrhizae: 50, Radix Cirsii Japonici: 50, Flos Chrysanthemi: 20.
With above medicine is fine powder altogether, encapsulated in, every day three times, each 6~9 the gram oral, ten days is a course of treatment.

Claims (3)

1. medicine for the treatment of apoplexy, it is characterized in that: it is made up of following components by part by weight:
Radix Angelicae Sinensis: 30~90, Rhizoma Chuanxiong: 40~80, the Radix Paeoniae Alba: 30~80, Radix Rehmanniae Preparata: 20~40, the Radix Rehmanniae: 20~40, Radix Ginseng 30~90, Pericarpium Citri Reticulatae: 10~30, Poria: 30~100, Fructus Aurantii: 30~70, Radix Platycodonis: 30~90, Cortex Cinnamomi: 20~50, Scorpio: 10~30, Radix Saposhnikoviae: 30~90, Bombyx Batryticatus: 20~40, Radix Angelicae Pubescentis: 20~40, Rhizoma Ligustici: 15~40, mentha leave: 30~100, Radix Bupleuri: 30~90, Gypsum Fibrosum: 30~70, Cortex Lycii: 10~30, Rhizoma Coptidis: 30~100, Fructus Foeniculi: 30~100, Semen Cuscutae: 10~30, Gecko: 30~70, Herba Ephedrae: 30~100, the strand Herba Chlorophyti: 30~90, Folium Ginkgo: 30~100, the Radix Linderae: 5~20, Radix Notoginseng: 5~20, the Rhizoma Atractylodis Macrocephalae: 10~30, Radix Salviae Miltiorrhizae: 5~30, the Rhizoma Pinelliae: 30~100, the Radix Aucklandiae: 30~100, Rhizoma Gastrodiae: 30~80, Rhizoma Et Radix Notopterygii: 30~80, Herba Asari: 5~20, the Rhizoma Anemarrhenae 30~70, Radix Scutellariae: 10~40, graceful Fructus Vitics Simplicifoliae: 10~40, the Cortex Eucommiae: 30~70, Radix Glycyrrhizae: 30~90, Radix Cirsii Japonici: 30~100, Flos Chrysanthemi: 10~50.
2. the medicine of treatment apoplexy according to claim 1 is characterized in that: it can be made up of following components by part by weight:
Radix Angelicae Sinensis: 40~70, Rhizoma Chuanxiong: 45~60, the Radix Paeoniae Alba: 40~60, Radix Rehmanniae Preparata: 25~35, the Radix Rehmanniae: 25~35, Radix Ginseng 40~70, Pericarpium Citri Reticulatae: 10~20, Poria: 40~70, Fructus Aurantii: 40~60, Radix Platycodonis: 40~70, Cortex Cinnamomi: 25~40, Scorpio: 10~20, Radix Saposhnikoviae: 40~70, Bombyx Batryticatus: 25~35, Radix Angelicae Pubescentis: 25~35, Rhizoma Ligustici: 15~30, mentha leave: 40~80, Radix Bupleuri: 40~70, Gypsum Fibrosum: 40~60, Cortex Lycii: 15~25, Rhizoma Coptidis: 40~70, Fructus Foeniculi: 40~70, Semen Cuscutae: 15~25, Gecko: 40~60, Herba Ephedrae: 40~70, the strand Herba Chlorophyti: 40~70, Folium Ginkgo: 40~80, the Radix Linderae: 10~15, Radix Notoginseng: 10~15, the Rhizoma Atractylodis Macrocephalae: 10~20, Radix Salviae Miltiorrhizae: 10~20, the Rhizoma Pinelliae: 40~70, the Radix Aucklandiae: 40~80, Rhizoma Gastrodiae: 40~60, Rhizoma Et Radix Notopterygii: 40~60, Herba Asari: 10~15, the Rhizoma Anemarrhenae 40~60, Radix Scutellariae: 15~30, graceful Fructus Vitics Simplicifoliae: 10~20, the Cortex Eucommiae: 40~60, Radix Glycyrrhizae: 40~70, Radix Cirsii Japonici: 40~80, Flos Chrysanthemi: 15~30.
3. the medicine of treatment apoplexy according to claim 1 is characterized in that: it can be made up of following components by part by weight:
Radix Angelicae Sinensis: 50, Rhizoma Chuanxiong: 50, the Radix Paeoniae Alba: 50, Radix Rehmanniae Preparata: 30, the Radix Rehmanniae: 30, Radix Ginseng 50, Pericarpium Citri Reticulatae: 15, Poria: 50, Fructus Aurantii: 50, Radix Platycodonis: 50, Cortex Cinnamomi: 30, Scorpio: 15, Radix Saposhnikoviae: 50, Bombyx Batryticatus: 30, Radix Angelicae Pubescentis: 30, Rhizoma Ligustici: 20, mentha leave: 50, Radix Bupleuri: 50, Gypsum Fibrosum: 50, Cortex Lycii: 20, Rhizoma Coptidis: 50, Fructus Foeniculi: 50, Semen Cuscutae: 20, Gecko: 50, Herba Ephedrae: 50, the strand Herba Chlorophyti: 50, Folium Ginkgo: 50, the Radix Linderae: 10, Radix Notoginseng: 10, the Rhizoma Atractylodis Macrocephalae: 15, Radix Salviae Miltiorrhizae: 10, the Rhizoma Pinelliae: 50, the Radix Aucklandiae: 60, Rhizoma Gastrodiae: 50, Rhizoma Et Radix Notopterygii: 50, Herba Asari: 10, the Rhizoma Anemarrhenae 50, Radix Scutellariae: 20, graceful Fructus Vitics Simplicifoliae: 15, the Cortex Eucommiae: 50, Radix Glycyrrhizae: 50, Radix Cirsii Japonici: 50, Flos Chrysanthemi: 20.
CNB011077506A 2001-01-16 2001-01-16 Medicine for treating apoplexy Expired - Fee Related CN1159037C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB011077506A CN1159037C (en) 2001-01-16 2001-01-16 Medicine for treating apoplexy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB011077506A CN1159037C (en) 2001-01-16 2001-01-16 Medicine for treating apoplexy

Publications (2)

Publication Number Publication Date
CN1365819A CN1365819A (en) 2002-08-28
CN1159037C true CN1159037C (en) 2004-07-28

Family

ID=4656658

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB011077506A Expired - Fee Related CN1159037C (en) 2001-01-16 2001-01-16 Medicine for treating apoplexy

Country Status (1)

Country Link
CN (1) CN1159037C (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100425169C (en) * 2006-01-09 2008-10-15 周显明 Chinese herbal health-caring beverage
CN101390986B (en) * 2008-11-14 2012-03-07 邵厚仁 Traditional Chinese medicine composition for cerebral thrombus and preparation method thereof
CN102078441B (en) * 2010-12-21 2012-01-04 李永泉 Pharmaceutical composition for treating hemiplegia
CN102327490A (en) * 2011-09-30 2012-01-25 荣成市崖头美全口腔诊所 Traditional Chinese medicine composition for treating apoplexia
CN103446452A (en) * 2012-05-30 2013-12-18 郑觉强 Capsule for curing hypertension, hyperglycemia and hyperlipidemia
CN104338076B (en) * 2014-10-23 2018-08-07 韩丽娜 A kind of Chinese medicine composition for treating apoplexy
CN105770758A (en) * 2016-04-22 2016-07-20 涂已文 Drug for treating stroke paralysis
CN106267135A (en) * 2016-11-07 2017-01-04 罗军 A kind of Pheretima cream and preparation method thereof
CN115429836B (en) * 2022-08-31 2023-09-12 天津中医药大学第一附属医院 Traditional Chinese medicine preparation for treating arrhythmia

Also Published As

Publication number Publication date
CN1365819A (en) 2002-08-28

Similar Documents

Publication Publication Date Title
CN1124153C (en) Medicinal composition for restoring cardiac collaterals and its application
CN100356972C (en) Chinese medicine for treating amblyopia and myopia
CN1298346C (en) Dynamic medicine for channels and collaterals and blood vessel
CN101628080A (en) Chinese medicinal capsule for tonifying kidney and strengthening yang
CN101062368A (en) Chinese traditional medicine for treating cirrhosis ascites
CN1159037C (en) Medicine for treating apoplexy
CN101062212A (en) Chinese medicinal herb composition for treating gastritis
CN1175835C (en) Medicine for treating cervical vertebra disease
CN101062347A (en) Chinese traditional medicine formula good for heart and brain
CN1218706C (en) Hepatitis B treaitng pill
CN1903321A (en) Traditional Chinese medicine pills for prolonging life and consolidating vital essential
CN101757206A (en) Chinese medicine preparation for treating chronic colitis
CN101167921A (en) Medicinal composition for treating stomachache and preparation process thereof
CN102813733A (en) Herb tea capable of resisting cancer, preventing diabetes mellitus and enhancing immunity
CN1240415C (en) Tablets against allergic purpura
CN101732423A (en) Chinese medicinal pills for treating hepatosplenomegaly
CN1209142C (en) Rongshuan jiannaokang thrombolytic
CN1245206C (en) Traditional Chinese medicine for treating pancreatitis
CN101129623A (en) Traditional Chinese medicine for treating anhypnia
CN101062236A (en) Astragalus radix pseudostell oral liquid
CN101095894A (en) Chinese traditional medicine composition for treating myocardium disease and method of making the same
CN1177489A (en) Chines medicine for treating vitiligo and preparation method thereof
CN101991762A (en) Traditional Chinese medicine for treating refractory asthma and preparation method thereof
CN101987150A (en) Chinese medicinal herb preparation for treating gout and preparation method thereof
CN1565544A (en) Medicine for treating cold disease

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee